Simon Vanveggel Selected Research

Simon Vanveggel Research Topics

8	Infections 12/2021 - 08/2012
8	Exanthema (Rash) 01/2017 - 01/2010
6	Dizziness (Lightheadedness) 03/2013 - 01/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2018 - 01/2018
2	Nausea 01/2014 - 01/2010
2	Coinfection 04/2013 - 08/2012
1	Fatigue 11/2021
1	Injection Site Reaction 01/2020
1	Pain (Aches) 01/2020
1	Sudden Death 09/2018
1	Myocardial Infarction 09/2018
1	Stroke (Strokes) 09/2018
1	Body Weight (Weight, Body) 01/2017
1	Dyslipidemias (Dyslipidemia) 08/2014
1	Vitamin D Deficiency 01/2014
1	Hypersensitivity (Allergy) 01/2014
1	Hepatitis B 04/2013
1	Vertigo (Positional Vertigo) 01/2010
1	Dyspepsia (Indigestion) 01/2010
1	Sleepiness 01/2010
1	Asthenia 01/2010
1	Schizophrenia (Dementia Praecox) 01/2004
1	Weight Gain 01/2004
1	Weight Loss (Weight Reduction) 01/2004

14	Rilpivirine (TMC-278)IBA 12/2021 - 01/2010
8	efavirenz (Sustiva)FDA Link 01/2014 - 01/2010
5	LipidsIBA 08/2014 - 01/2010
4	cabotegravirIBA 12/2021 - 01/2020
3	TabletsIBA 01/2018 - 04/2013
2	dolutegravirIBA 01/2020 - 01/2018
2	Darunavir (Prezista)FDA Link 09/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2014
2	NucleosidesIBA 04/2013 - 08/2012
2	Reverse Transcriptase InhibitorsIBA 04/2013 - 08/2012
1	lamivudine drug combination abacavir FDA Link 01/2020
1	Emtricitabine (Emtriva)FDA Link 01/2018
1	tenofovir alafenamideIBA 01/2018
1	cobicistat mixture with darunavirIBA 01/2018
1	etravirine (TMC-125)FDA Link 01/2017
1	CreatinineIBA 01/2017
1	Cytochrome P-450 CYP2C19IBA 01/2017
1	Cytochrome P-450 CYP2C9IBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2014
1	Tenofovir Drug Combination Rilpivirine EmtricitabineIBA 04/2013
1	Aripiprazole (Abilify)FDA Link 01/2004
1	Olanzapine (Zyprexa)FDA Link 01/2004
1	Antipsychotic Agents (Antipsychotics)IBA 01/2004